Replies to post #222663 on Biotech Values

[DewDiligence]

ABBV—The $10B figure in that write-up is misleading since ABBV will never have to pay the $4B in contingent milestones (#msg-122248289).

[DewDiligence]

ABBV lays off Stemcentryx workers, effectively ending the program (which was already on life support):

https://endpts.com/first-abbvie-chopped-a-phiii-then-they-wrote-off-4b-billion-in-book-value-now-178-stemcentrx-workers-are-getting-the-ax